This site is intended for healthcare professionals only
LoginRegister
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusCDSCO Panel Approves AstraZeneca's Protocol Amendment for Anti-cancer Drug AZD0901 study
JnJ wins USFDA approval for subcutaneous Rybrevant Faspro for EGFR-Mutated NSCLCJohnson and Johnson Gets CDSCO Panel nod for Additional Indication of Ustekinumab solution for...
Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancerEMA Committee recommends EU label update for Roche Phesgo to allow administration outside of...
Bayer new drug application for gadoquatrane accepted for review in ChinaBayer begins Phase I study targeting GPC3 with alpha radiopharmaceutical in advanced hepatocellular...
AstraZeneca Pharma India Slapped Rs 11.88 Cr Tax Adjustment for FY23, to Move ITATAstraZeneca Breztri met primary endpoints in Phase III trials in asthma
Not a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent RestrictionsNot a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent Restrictions
Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, EuropeCDSCO Panel Approves Dr Reddy's Laboratories Protocol Amendment Proposal to study Abatacept
Novartis concludes acquisition of Tourmaline BioCDSCO Panel Approves Novartis Healthcare's Protocol Amendment to study Iptacopan
Rajasthan govt set to revive Rajasthan Drugs and PharmaRajasthan govt set to revive Rajasthan Drugs and Pharma
Torrent Pharma Gets Zero USFDA Observations for Dahej PlantNovo Nordisk application for oral Wegovy accepted by USFDA for weight loss
GSK Pharma names Sukanya Choudhury as Regulatory Head, Growth Emerging MarketsGSK Pharma names Sukanya Choudhury as Regulatory Head, Growth Emerging Markets
Sanofi India appoints Haresh Vala as Company Secretary, Compliance OfficerSanofi Consumer Healthcare India Q1 results PAT up 12.9%
X